Principal Street Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Principal Street Partners's AMGN Position: Q1 2026 in Review
Principal Street Partners reduced its Amgen (AMGN) stake by 1.2% in Q1 2026, selling an estimated $87.7K and leaving 20,496 shares worth $7.21M. The position accounts for 1.18% of the portfolio, ranked #34.
Principal Street Partners first reported a position in AMGN in Q3 2019 and has held it in 27 quarters since. The position peaked at $13.3M in Q1 2021. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Principal Street Partners held 20,496 shares of Amgen worth $7.21M as of Q1 2026.
- Principal Street Partners sold 246 Amgen shares in Q1 2026, an estimated $87.7K.
- Amgen made up 1.18% of Principal Street Partners's portfolio in Q1 2026, its #34 holding.
- Principal Street Partners first reported a position in Amgen in Q3 2019 and has held it in 27 quarters since.
- Principal Street Partners's Amgen position peaked at $13.3M in Q1 2021.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Principal Street Partners's 13F filing for Q1 2026, filed 15 May 2026.